Kidney transplantation in AL amyloidosis: Is it time to maximize access? Research Letter


Authors: Sathick, I. J.; Rosenbaum, C. A.; Gutgarts, V.; Landau, H.
Title: Kidney transplantation in AL amyloidosis: Is it time to maximize access?
Keywords: adult; clinical article; human tissue; treatment response; middle aged; human cell; overall survival; prednisone; letter; quality of life; bortezomib; cohort analysis; creatinine; dexamethasone; melphalan; autologous stem cell transplantation; creatinine blood level; herpes zoster; stem cell transplantation; recurrent disease; glomerulus filtration rate; tacrolimus; light chain amyloidosis; cyclosporine; lung aspergillosis; thymocyte antibody; kidney transplantation; viremia; basiliximab; al amyloidosis; end stage renal disease; renal replacement therapy; mycophenolate mofetil; peritoneal dialysis; human; male; female; priority journal
Journal Title: British Journal of Haematology
Volume: 188
Issue: 3
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2020-02-01
Start Page: e1
End Page: e4
Language: English
DOI: 10.1111/bjh.16246
PUBMED: 31730739
PROVIDER: scopus
DOI/URL:
Notes: Letter -- Export Date: 2 March 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Heather Jolie Landau
    419 Landau